Skip to Content

Capabilities

37 Years Of Know-How &
Continuing To Innovate To
Stay On The Leading Edge

Pellucid Pharma develops end-to-end pharmaceutical and nutraceutical solutions. We develop pharmaceutical drugs and products while simultaneously deploying innovative and patented technologies used for their administration.

We are an integrated pharma company providing a wide range of services to our clients and partners with an unflinching focus on quality and reliability. Our high-production capacities and advanced R&D technologies make us one of the most important companies in the field of fast-melt ODTs (oral dissolving tablets) worldwide.

Our drug delivery systems and dosage forms maximise the utility drawn from our drug APIs (Active Pharmaceutical Ingredients), promoting successful treatments based on precise dosage and efficient delivery. This gives more control to medical practitioners and reduces redundancy during manufacture.

OUR SERVICES
About Pellucid Pharma

With 100+ patents, we have commercialised over 150 different products and established ourselves as a benchmark in the healthcare industry with more than 200 million units sold annually. As a Swiss-based global company, our pharmaceuticals, innovative medicines, nutraceuticals, and delivery systems are distributed across the world’s most demanding markets. Operating in a highly regulated sector, we adopt a high-watermark approach to compliance to exceed all applicable international standards.

Industry Competence

Our Industry-Explicit
Competence

We are an integrated pharma company. And in addition to our key activities, we provide a wide range of services to our clients and partners. Doing so with a rigorous focus on quality and reliability.

Our high production capacities and advanced R&D technologies make us one of the most important companies in the field of fast-melt ODT’s (oral dissolving tablets) in the world.

On The Leading Edge Of
Pharmaceuticals Over The
Past Four Decades

Our company was born in 1988 as Aesculapius Pharma with a focus on effervescent formulations. Four years later, Aesculapius was acquired by Élan Pharma, during which we developed and commercialised the world’s first fast-melt product.

In 2004, the company’s majority shares were acquired by Sanders, Morris, Harris (SMH) funds, and it was rebranded as Alpex Pharma SA. In the following years, we developed and distributed dozens of innovative drugs and supplements across Europe, the Americas, and Australia.

In 2021, Alpex broke ground on facility expansion for further global growth and launched projects focusing on longevity and novel medicine development.

As a research-based pharmaceutical company, we drive rapid growth and combat disease by developing innovative medicinal products.

Alpex is uniquely positioned with both Nutraceutical & Pharma R&D & Production under one roof enabling our partners to migrate and focus across both sectors with the same partner.

Pharma companies are increasingly seeking to develop nutraceutical formulations and new products to tap into the explosive consumer spending on preventative health.

We develop proprietary life-extending formulations supporting global ageing populations and addressing the rapidly expanding longevity market.

We invest heavily in developing and scaling novel medicines and supplements targeting high-growth segments in pharma and nutraceuticals and longevity.

Developing life-changing treatments for the world’s rarest ailments.

Our Strategic Capabilities

At Pellucid Pharma, our capabilities are designed to solve the real-world challenges of global API sourcing — where compliance, continuity, and control must coexist. Each capability is structured to reduce risk, protect regulatory outcomes, and support long-term commercial success.

🔍

Rigorous Supplier Qualification

Manufacturers are selected based on regulatory history, technical capability, quality systems, and financial stability. We go beyond basic audits to evaluate inspection outcomes, warning letter exposure, capacity scalability, and consistency across batches. Acting as your on-ground intelligence partner, we continuously monitor supplier performance to ensure alignment with evolving regulatory and commercial expectations.

This disciplined qualification process helps prevent downstream surprises during audits, filings, or scale-up.

⚠️

Proactive Risk Mitigation

We don’t wait for disruptions — we anticipate them. Through active market surveillance, demand forecasting, and supplier risk profiling, we identify potential shortages, capacity constraints, or regulatory threats well in advance. Our alternate sourcing strategies are pre-qualified and ready, ensuring continuity even during geopolitical events, regulatory actions, or raw material volatility.

The result is a resilient supply chain designed to absorb shocks without impacting your production or approvals.

📄

Technical Documentation & Traceability

Documentation is treated with the same seriousness as the API itself. From complete batch traceability and analytical method support to DMF alignment and variation readiness, we ensure your documentation package remains accurate, current, and inspection-ready. Our structured documentation control reduces regulatory queries, shortens approval timelines, and strengthens audit confidence across markets.

We understand that strong documentation is not administrative overhead — it is a regulatory asset.

🔬

Lifecycle Support (Lab to Commercial)

API needs evolve across a product’s lifecycle — and our supply models evolve with you. We support development quantities, validation batches, and large-scale commercial volumes, all sourced from qualified and scalable manufacturers. This continuity minimizes change-related risks and supports smoother technology transfer, validation, and post-approval stability.

Whether you are advancing a pipeline molecule or expanding an approved product globally, we help ensure supply readiness at every stage.

🔄

Agile Change Management

In regulated markets, change is inevitable — but unmanaged change is risky. Specification updates, manufacturing site changes, or process optimizations are handled with full transparency, structured communication, and regulatory alignment. We coordinate documentation updates, impact assessments, and stakeholder notifications to ensure compliance is maintained without disrupting supply.

Our disciplined change management approach protects both your filings and your timelines.

🧭

Strategic Oversight & Partner Alignment

Beyond execution, we provide strategic oversight to align sourcing decisions with your long-term regulatory and commercial goals. By understanding your market roadmap, filing strategy, and volume projections, we help you make informed API decisions that remain viable not just today — but years into commercialization.

🤝

A Capability-Driven Partnership

Each of these capabilities works together as part of an integrated sourcing framework — one that prioritizes clarity, control, and confidence. With Pellucid Pharma, you gain more than operational support. You gain a sourcing partner built to protect your approvals, strengthen your supply chain, and support sustainable growth in global markets.